$0.48
Affimed is a biotechnology business based in the US. Affimed shares (AFMD) are listed on the NASDAQ and all prices are listed in US Dollars. Affimed employs 219 staff and has a trailing 12-month revenue of around $34.1 million.
How to buy Affimed stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – AFMD. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
eToro
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
tastytrade
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Affimed stock price (NASDAQ: AFMD)
Use our graph to track the performance of AFMD stocks over time.Affimed shares at a glance
Latest market close | $0.49 |
---|---|
52-week range | $0.45 - $2.55 |
50-day moving average | $0.56 |
200-day moving average | $0.87 |
Wall St. target price | $5.96 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.78 |
Buy Affimed stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Affimed stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Affimed price performance over time
Historical closes compared with the close of $0.486 from 2023-09-20
1 week (2023-09-14) | -4.14% |
---|---|
1 month (2023-08-22) | -6.00% |
3 months (2023-06-22) | -28.53% |
6 months (2023-03-22) | -35.20% |
1 year (2022-09-22) | -76.06% |
---|---|
2 years (2021-09-22) | -92.33% |
3 years (2020-09-22) | 3.5 |
5 years (2018-09-21) | 4.375 |
Affimed financials
Revenue TTM | $34.1 million |
---|---|
Gross profit TTM | $41.8 million |
Return on assets TTM | -34.45% |
Return on equity TTM | -76.31% |
Profit margin | 0% |
Book value | $0.66 |
Market Capitalization | $71.7 million |
TTM: trailing 12 months
Affimed share dividends
We're not expecting Affimed to pay a dividend over the next 12 months.
Affimed share price volatility
Over the last 12 months, Affimed's shares have ranged in value from as little as $0.4508 up to $2.55. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Affimed's is 2.1062. This would suggest that Affimed's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Affimed overview
Affimed N. V. , a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and Europe. Its lead product candidates include AFM13 that has completed Phase 2 clinical trial for CD30-positive lymphoma, Phase II clinical trial for hodgkin lymphoma, and completed Phase II clinical study for peripheral T-cell lymphoma; AFM24, a tetravalent, bispecific epidermal growth factor receptor, and CD16A-binding innate cell engager, which is in Phase IIa clinical trial for the treatment of advanced cancers; and AFM28, an innate cell engager (ICE), which is in preclinical development to treat acute myeloid leukemia. The company also develops AFM32, an ICE candidate that is in preclinical development for the treatment of solid tumors. In addition, it has collaboration with Artiva Biotherapeutics to develop the combination of AFM13 with Artiva's AB-101 NK cell therapy; license and strategic collaboration agreement with Roivant Sciences Ltd. to develop and commercialize novel ICE molecules, including AFM32, in oncology; and research collaboration and license agreement with Genentech for the development and commercialization of certain product candidates, which includes novel NK cell engager-based immunotherapeutics to treat multiple cancers.
Affimed in the news
Affimed to Present at the Cantor Global Healthcare Conference 2023
Affimed Receives FDA Fast Track Designation for AFM13 in Combination with AlloNK® for the Treatment of Patients with Relapsed or Refractory Hodgkin Lymphoma
Affimed to Present at the H.C. Wainwright Annual Global Investment Conference
Frequently asked questions
What percentage of Affimed is owned by insiders or institutions?Currently 4.705% of Affimed shares are held by insiders and 54.263% by institutions. How many people work for Affimed?
Latest data suggests 219 work at Affimed. When does the fiscal year end for Affimed?
Affimed's fiscal year ends in December. Where is Affimed based?
Affimed's address is: Technologiepark, Heidelberg, Germany, 69120 What is Affimed's ISIN number?
Affimed's international securities identification number is: NL0010872420 What is Affimed's CUSIP number?
Affimed's Committee on Uniform Securities Identification Procedures number is: N01045108
More guides on Finder
-
How to buy Discord stock when it goes public
Everything we know about the Discord IPO, plus information on how to buy in.
-
Today’s trending Reddit stocks
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
-
How to buy Tottenham Acquisition I stock
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
-
How to buy TotalEnergies stock
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
-
How to buy Thunder Bridge Acquisition stock
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
-
How to buy Switchback Energy Acquisition Corporation stock
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
-
How to buy Telefonica SA ADR stock
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
-
How to buy Faraday Future stock
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
-
How to buy Phoenix Tree stock
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
-
How to buy Innate Pharma stock
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.
Ask an Expert